Literature DB >> 2878178

Kaposi's sarcoma: a reversible hyperplasia.

J J Brooks.   

Abstract

Kaposi's sarcoma has many unusual features: for example, the pronounced male preponderance; its appearance in "crops" rather than as primary tumour with metastases; a substantial rate of spontaneous remission; the predictability of involved sites; the lack of aneuploidy; and the strong association with immunodeficiency. These features and other evidence suggest that it is not a malignant neoplasm but a benign, potentially controllable and reversible hyperplasia.

Entities:  

Mesh:

Year:  1986        PMID: 2878178     DOI: 10.1016/s0140-6736(86)91436-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Ultrastructural development of Kaposi's sarcoma in relation to the dermal microvasculature.

Authors:  M Dictor; B Carlén; N Bendsöe; L Flamholc
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  HIV-associated Kaposi's sarcoma: new developments in epidemiology and molecular pathology.

Authors:  W K Roth
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Kaposi's sarcoma tumor cells preferentially express Bcl-xL.

Authors:  K E Foreman; T Wrone-Smith; L H Boise; C B Thompson; P J Polverini; P L Simonian; G Nunez; B J Nickoloff
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Molecular analysis of clonality in Kaposi's sarcoma.

Authors:  E Delabesse; E Oksenhendler; C Lebbé; O Vérola; B Varet; A G Turhan
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 5.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

6.  Lymphaticovenous differentiation in Kaposi's sarcoma. Cellular phenotypes by stage.

Authors:  M Dictor; C Andersson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 7.  Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.

Authors:  Narayanan Sathish; Yan Yuan
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 8.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

9.  Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.

Authors:  M U Rahman; A Mazumder
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

10.  A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

Authors:  Henry H Chang; Don Ganem
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.